GSK-J4,
GSKJ4 compound,
GSK-J4,
GSK J4,
1373423-53-0,
Ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate,
N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine ethyl ester,
gsk-j4-hcl,
GSK J4 hydrochloride,
GSKJ4,
GTPL8979,
CHEMBL3183531,
SCHEMBL14931829,
CHEBI:95077,
GSK J4 HCl (GSKJ4 HCl),
BCP08261,
3706AH,
HY-15648B,
MFCD22683852,
ZINC95537775,
AKOS024458241,
CS-3986,
GSK-J4, >=98% (HPLC),
SB19351,
BC600765,
SC-21244,
FT-0700444,
J3.586.394J,
J-007003,
BRD-K98203492-001-01-1,
ethyl 3-((2-(pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)pyrimidin-4-yl)amino)propanoate,
ethyl 3-(6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-ylamino)propanoate,
ethyl 3-{[2-(pyridin-2-yl)-6-(2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl)pyrimidin-4-yl]amino}propanoate,
N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-?-alanine ethyl ester,
GSKJ4 compound,
GSK J4 HCl,
C24H27N5O2,
A12732,
C000593030,